Catheter Thrombosis Trials
United Kingdom, Reading
United Kingdom, London
This is a post-market, observational, retrospective multi-center Registry designed to gather information on the performance of the Angel® Catheter in general clinical practice.
Cancer patients with Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) will be treated with Low Molecular Weight Heparin (LMWH) and apixaban. Study duration is 12 weeks.
The objective is to determine the incidence of thrombosis on central venous catheters in patients hospitalized in a surgical critical care unit, in the immediate postoperative period of urological or digestive carcinological surgery, and receiving parenteral nutrition.
The central venous catheters (CVC) related thrombosis is an issue of importance to ICU clinicians.This study conducts the daily ultrasound-screening for CVC-related thrombosis (DUCT).Its aim is to evaluate the characteristic and regularity of the central venous catheters (CVC) r...
Connect with PatientWingLike Us Follow Us
Get all the latest studies in your inbox! Sign up for the PatientWing newsletter today!Sign me up
Looking to enroll patients? List your studies here
Streamline your enrollment process and get better qualified patients through PatientWing.Get started
Healthy and want to help?
By participating in clinical trials, you help advance the medical science and may be compensated for your time. Hooray!!See what's available